Discover; Or simply tell us… How you would like your lactose! The management system of Molkerei MEGGLE Wasserburg has been certified as meeting the requirements of GMP and GDP according to EXCiPACTSimply fill out the form below to contact MEGGLE Excipients & Technology now.Read the latest Pharmaceutical news and content
4, pp. This monograph is harmonized between USP-NF, Ph. h�bbd```b``���� �A���i`Y�8���5���A��&�IF�0[,˸D��L����H�� ��lW(ؖ �?��� �?`qF*����|0 3`
We have taken this knowledge and developed the Aero Flo® Brand Inhalation Grades of lactose that are specifically developed for dry powder inhalation (DPI) applications. Depending on the active ingredient and type of inhaler, specific particle size distributions and blends are necessary to achieve the required functionality. endstream
endobj
startxref
The micronized grade InhaLacAll products are delivered in 10, 15 or 25Kg cartons with various combination of double PE-EVOH-PE Inliner and/or aluminum laminated (OPP-ALU-PE) inliner (see Packaging and Stability Table below) .All MEGGLE dry powder inhalation products conform to the monograph “Lactose Monohydrate” in the USP-NF.). Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations Eur J Pharm Biopharm. Dry powder inhalation challenges. influential leaders within the
Easily find the suitable lactose for your formulation project : Simply select your application, & narrow your search by precising options from the menus below : desired Particle Size Distribution, Density parameters … %%EOF
H. Larhrib, G. P. Martin, D. Prime, and C. Marriott, “Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers,” European Journal of Pharmaceutical Sciences, vol. %PDF-1.6
%����
Our Mobile App is now available!A unique network of decision makers and
The present study deals with the quantification of amorphous content in lactose and its influence on dry powder inhaler formulations. Lactose is the most important carrier substance for formulations for pulmonary administration as Dry Powder Inhalers (DPI). Inhalation aerosols enable needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins.
131 0 obj
<>/Filter/FlateDecode/ID[<7CF2E4A7D9849546BF9603CFE69C9E50><61626FF82F80F346B95E68B8393E7617>]/Index[108 40]/Info 107 0 R/Length 115/Prev 723153/Root 109 0 R/Size 148/Type/XRef/W[1 3 1]>>stream
In the formulation of inhalants, milled, micronised and sieved lactose qualities are used. Eur. 0
Copyright 2020 Building on a long and well established history of supplying world class pharmaceutical grade lactose, film coatings, and tableting systems, Kerry introduces Aero Flo® Inhalation lactose, designed to meet the growing demand for lactose that is suitable for developing dry powder inhalers. InhaLac® milled/micronized dry powder inhaler lactose grade, distribution density Distribution density q3lg(x) 0.1 1 10 100 1000 Particle size (μm) InhaLac®400InhaLac® 500 1.2 1.0 0.8 0.6 0.4 0.2 0 100 80 60 40 20 0 Batch-to-batch consistency Batch-to-batch consistency for all lactose products can be attributed to MEGGLE’s long history and experience in lactose manufacture, … Effective performance of a dry powder inhaler largely depends on the carrier material (excipient) used for the drug formulation. on the go. 19, no. A range of lactose grades from coarse crystals to fine powders for Dry Powder Inhalers & Nasal Drug Delivery. h�b```f``�����pu7� ��X8:xӧ�i40p6\�q� `g����>D%ˢ3f�aBݭ�=��X=M��y|���0�9���#��_`��Mꮜ�[�M�p c�����c*�]hh*M�ca``K�`
m ��&%%�\#X�$���q�``H�]�����E�X ��P>��]
�77e�2Zg�7]@4�1��HT��:�������*�;��#��� 뙢�� 211–221, 2003. Dry Powder Inhaler Kerry has a long, and well established history of supplying world class lactose, mainly for oral solid dose and capsule filling applications. Lactose monohydrate has become an industry standard in dry powder inhalation (DPI) formulation development, which needs to overcome a series of ongoing challenges.Using lactose as an excipient meets these challenges by not only improving performance efficiency of the inhaler, but also facilitating powder handling during production.MEGGLE’s highly controlled production process produces a range of precisely quantified high quality grades for inhalation with narrow particle size distribution (PSD) in which the particles retain individual identities and behaviors.All sieved and milled InhaLac products do have a retest date of 24 months.